Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BPX-401 by Bellicum Pharmaceuticals for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
BPX-401 is under clinical development by Bellicum Pharmaceuticals and currently in Phase II for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic...
Data Insights
BPX-401 by Bellicum Pharmaceuticals for Non-Hodgkin Lymphoma: Likelihood of Approval
BPX-401 is under clinical development by Bellicum Pharmaceuticals and currently in Phase II for Non-Hodgkin Lymphoma. According to GlobalData, Phase...